Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SRPT Transcript
Sarepta Therapeutics, Inc. (SRPT) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call summary highlights a 20% YoY revenue growth and a shift from a net loss to a $50 million net income, indicating strong financial performance. The increase in R&D expenses supports future growth, while improved cash flow reflects efficient management. Despite the lack of strategic and operational updates, the financial results and positive market demand for new therapies suggest a strong positive sentiment. The absence of negative feedback in the Q&A further supports this outlook.
Sarepta Therapeutics, Inc. (SRPT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Neutral3-3
Sarepta Therapeutics, Inc. (SRPT) Q4 2025 Earnings Call Transcript
Unknown2-25
The earnings call highlights a mix of positive and negative factors. While there is a 16% revenue increase and promising product developments, significant cost of sales and operating losses are concerning. The Q&A reveals uncertainties in CEO succession and market dynamics, while management's unclear responses further cloud the outlook. The absence of market cap data limits prediction precision, but the neutral sentiment suggests a stock movement within -2% to 2%.
Sarepta Therapeutics, Inc. (SRPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
SRPT Slides
SRPT Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
